MI Law May Prevent Recovery of Millions Spent Fighting Opioid Crisis
As the nation’s opioid crisis continues 162 of the 600 people recently charged with healthcare fraud were healthcare professionals who contributed to the nation’s fastest and most deadly epidemic. Conducted nationwide, this was the largest health care fraud investigation. Last year, more than 400 people were charged, 115 of them were doctors, nurses and other healthcare professionals […]
Plaintiff wins Bellwether Xarelto Case in Philadelphia Court
A Philadelphia jury awarded Lynn Hartman $27.8 million after finding drug manufacturers Johnson & Johnson and Bayer failed to warn about the dangers of their blood thinning drug Xarelto. The verdict includes $26 million in punitive damage, which juries award to plaintiffs when they believe the defendant acted egregiously. This bellwether case tried in Pennsylvania […]
HHS Pick, Former Eli Lilly Exec, Grilled over Zyprexa Scandal
High Court Won’t Hear Sheller Dispute with FDA over Risperdal
High Court Won’t Hear Dispute Challenging FDA Over J&J Drug Supreme Court won’t weigh in on whether law firm can sue FDA over drug labeling Circumstances in which third parties can sue over government actions remain unclear By Dana A. Elfin A Philadelphia-based law firm has hit the end of the road in its bid […]
Essure Birth Control: Update
Long term data about the Essure contraceptive device suggest that it may pose risks of serious complications. Essure is a birth control device that consists of two metal coils placed inside the fallopian tubes to block conception. Thousands of women across the country have reported serious side effects associated with the device, including severe and/or chronic pain, […]
Invokana: FDA Warnings on SGLT2 Diabetes Drugs
Sheller, P.C. attorneys are investigating the newer class of diabetes drugs following FDA warnings. ABOUT THE DRUGS Invokana (Invokamet) is a relatively new SGLT2 inhibitor diabetes drug that is intended to be used in combination with diet and exercise to improve glycemic control and lower blood sugar in adults with type 2 diabetes mellitus. When […]
#6 & #11 PA SETTLEMENTS 2014
American Lawyer Media’s Top Pennsylvania Verdicts and Settlements for 2014 reveals Sheller, P.C. in a familiar spot again in 2014. The firm has been at or near the top of the list for five of the last six years. This year the firm pulled both the #6 and #11 Top Settlements spots based on its […]
$520 MILLION SETTLEMENT
April 27, 2010: In the third record whistleblower settlement for Sheller, P.C. in fifteen months, the firm represented a whistleblower who brought forth knowledge of wrongdoing by AstraZeneca. AstraZeneca agreed to a civil settlement of $520 million for charges of off-label marketing of the powerful antipsychotic drug Seroquel. The settlement is the largest pharmaceutical civil settlement […]
J&J Loses Trial Over Risperdal and Male Breast
The Wall Street Journal Pharmalot Blog 2015-02-24 In a setback to Johnson & Johnson, a Philadelphia jury decided the health care giant must pay $2.5 million in damages for failing to warn that its Risperdal antipsychotic could cause gynecomastia, which is abnormal development of breasts in males. The lawsuit was brought by the family of […]
$58.9 MILLION SETTLEMENT
The Sheller whistleblower team announced a $58.9 milllion settlement with Shire Pharmaceuticals over off-label marketing of ADHD drugs Adderall and Vyvanse in September, 2014. Court documents detailing the civil allegations and settlement were signed by Shire and unsealed by the Office of the United States Attorney for the Eastern District of Pennsylvania. A Shire executive, […]
